Catalyst Wire Dossier Catalyst Wire Dossier

APIC-CF Therapy

· Cytonics Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for APIC-CF Therapy, covering 2015-08-21 to 2015-08-21. Get the full timeline:

Most recent: Clinical Trial Update: APIC-CF Therapy for Mild to Moderate Osteoarthritis of the Knee [Phase 1, Phase 2]

See pricing